TRANSFECTION REAGENTS AND EQUIPMENT MARKET ANALYSIS
Global Transfection Reagents and Equipment Market: Key Developments
In August 2021, Mirus Bio announced the launch of the TransIT VirusGEN GMP product line. This expansion to the existing TransIT VirusGEN product line complies with good manufacturing practice (GMP) viral vector manufacturing to support cell and gene therapy development and process activities through to GMP commercial scale.
In June 2021, Qiagen NV launched QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency to determine how their interventions have changed the function of the DNA sequence.
In May 2021, Lonza Group announced the launch of the Next Generation 4D-Nucleofector Cell Transfection Platform with proven performance and enhanced ease of use.
In April 2021, BOC Sciences launched the new generation non-viral in vivo transfection reagents platform to deliver a variety of samples to targeted organs (including kidney, liver, and pancreas).
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
